ALLENA PHARMACEUTICALS BOSTON
Allena Pharmaceuticals is a biotechnology company that focuses on the development and commercialization of non-systemic protein therapeutics. The company's main objective is to create innovative treatments for patients with rare and severe metabolic and kidney disorders. One of their notable achievements includes the positive topline results from the URIROX-1 Trial and from Study 206, which are significant contributions to the medical field.
ALLENA PHARMACEUTICALS BOSTON
Social Links:
Industry:
Biotechnology
Founded:
2011-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.allenapharma.com
Status:
Active
Similar Organizations
Adicet Bio
Adicet Bio is a biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for cancer
Adnovate Clinical
Adnovate Clinical is a biotechnology industry.
AlphaThera
AlphaThera is a biotechnology industry.
Functional Biosciences
Functional Biosciences is a biotechnology industry firm.
Landmark Bio
Landmark Bio is a biotechnology industry.
RAGE Biotech
RAGE Biotech is a biotechnology industry.
Current Advisors List
Founder
More informations about "Allena Pharmaceuticals Boston"
Allena Pharmaceuticals - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 215-791-0105 Allena Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to discovering, developing and …See details»
Allena Pharmaceuticals, Inc. | LinkedIn
Allena Pharmaceuticals is dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic disorders that affect the kidney.See details»
Allena Pharmaceuticals, Inc. - AnnualReports.com
Allena Pharmaceuticals, Inc. is a late-stage biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and …See details»
Allena Pharmaceuticals Boston - Crunchbase Company Profile
Allena Pharmaceuticals is a biotechnology company that focuses on the development and commercialization of non-systemic protein therapeutics. The company's main objective is to …See details»
Allena Pharmaceuticals, Inc. - Dun & Bradstreet
Website: www.allenapharma.com Employees (this site):? Modelled. Unlock full sales materials and reports Dynamic search and list-building capabilities. Real-time trigger alerts. …See details»
Allena Pharmaceuticals - PitchBook
Allena Pharmaceuticals General Information Description. Allena Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company engaged in developing and commercializing first-in …See details»
Overview, News & Similar companies - ZoomInfo.com
Jul 12, 2022 www.allenapharma.com. Revenue $7.1 Million. Stock Symbol ALNA. Industry Pharmaceuticals Healthcare . Recent News & Media. Allena Pharmaceuticals, Inc. Terminates …See details»
Allena Pharmaceuticals (USA) Funding: $198.8M - Medical Startups
Nov 26, 2024 Allena Pharmaceuticals is dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic disorders that …See details»
Allena Pharmaceuticals - Craft
Nov 8, 2022 Allena Pharmaceuticals has 4 employees across 2 locations. See insights on Allena Pharmaceuticals including office locations, competitors, revenue, financials, executives, …See details»
Allena Pharmaceuticals to Present at Upcoming Investor …
NEWTON, Mass., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage biopharmaceutical company dedicated to developing and …See details»
Massachusetts-Based Startup Allena Pharma Banks $53 Million
Dec 9, 2015 Allena Pharmaceuticals, Inc., a specialty biopharmaceutical company focused on developing and commercializing innovative non-systemic oral protein therapeutics to treat …See details»
Allena Pharmaceuticals Announces Rescheduling of Special …
NEWTON, Mass., July 05, 2022 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and …See details»
Allena Pharmaceuticals Announces $28 Million Registered
NEWTON, Mass., July 13, 2021 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and …See details»
Allena Pharmaceuticals Launches with $15 Million Series A Round
Nov 16, 2011 Allena Pharmaceuticals Launches with $15 Million Series A Round. Company Developing Non-Systemic Protein Therapeutics for Metabolic Disorders; Founded by Proven …See details»
Allena Pharmaceuticals, Inc. to Present at the Ladenburg Thalmann …
NEWTON, Mass., July 08, 2021 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage biopharmaceutical company dedicated to discovering, developing and …See details»
Working at Allena Pharmaceuticals - Glassdoor
Allena Pharmaceuticals is dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic disorders that affect the kidney.See details»
Allena Pharmaceuticals Provides Clinical and Corporate
Jan 4, 2022 ALLN-346, an orally administered enzyme in development for the treatment of hyperuricemia and gout, demonstrates a statistically significant reduction in serum uric acid …See details»
Allena Pharmaceuticals Announces Initial Data from Phase 1
Nov 30, 2020 This release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 including, without limitation, statements …See details»
Allena Pharmaceuticals Achieves Alignment With FDA on Phase 3 …
Allena Pharmaceuticals, Inc. recently announced it has reached alignment with the US FDA on both the design of URIROX-2, its second pivotal Phase 3 trial of reloxaliase in patients with …See details»
HGH for Weight Loss - Allena Pharmaceuticals
Aug 1, 2024 [email protected] $ 0.00 0 Cart 0.00 0 Cart. Store; Contact us; FAQ; Lab tests on hgh; BlogSee details»